| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5683219 | Progrès en Urologie | 2017 | 7 Pages |
Abstract
Our results showed that molecular analyses of superficial bladder cancers based on urinary DNA and the BCA-oligo test could be used as prognostic factor for the tumor evolution, allowing then a more adapted clinical management.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
P. Léon, G. Cancel Tassin, K. Sighar, E. Compérat, C. Gaffory, V. Ondet, S. Hugonin, M. Audouin, S. Doizi, O. Traxer, C. Ciofu, M. Rouprêt, R. Lacave, O. Cussenot,